Cargando…
A systematic review and meta-analysis of glucocorticoids treatment in severe COVID-19: methylprednisolone versus dexamethasone
OBJECTIVE: The preferred agent of glucocorticoids in the treatment of patients with severe COVID-19 is still controversial. This study aimed to compare the efficacy and safety of methylprednisolone and dexamethasone in the treatment of patients with severe COVID-19. METHODS: By searching the electro...
Autores principales: | Hong, Shukun, Wang, Hongye, Li, Shuyuan, Liu, Jian, Qiao, Lujun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162003/ https://www.ncbi.nlm.nih.gov/pubmed/37147596 http://dx.doi.org/10.1186/s12879-023-08280-2 |
Ejemplares similares
-
The roles of methylprednisolone treatment in patients with COVID-19: A systematic review and meta-analysis
por: Hong, Shukun, et al.
Publicado: (2022) -
Effects of different doses of methylprednisolone on clinical outcomes in patients with severe community-acquired pneumonia: a study protocol for a randomized controlled trial
por: Hong, Shukun, et al.
Publicado: (2022) -
Effects of different doses of methylprednisolone therapy on acute respiratory distress syndrome: results from animal and clinical studies
por: Hong, Shukun, et al.
Publicado: (2022) -
The roles of noninvasive mechanical ventilation with helmet in patients with acute respiratory failure: A systematic review and meta-analysis
por: Hong, Shukun, et al.
Publicado: (2021) -
METHYLPREDNISOLONE VERSUS DEXAMETHASONE FOR TREATMENT OF SEVERE OR CRITICAL COVID-19: A QUASI-EXPERIMENTAL STUDY (MD TREAT)
por: Nasir, N., et al.
Publicado: (2023)